ARTICLE | Clinical News
NeuroStar TMS Therapy System regulatory update
June 11, 2012 7:00 AM UTC
Neuronetics said it received CE mark approval for NeuroStar TMS therapy to treat major depressive disorder (MDD) in adult patients who have failed to receive satisfactory improvement from antidepressa...